ADP Stock Cash Flow Statements

ADP LLC Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Free Cash Flow

Capital Expenditure

ADP LLC Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-03-31	2024-12-31	2024-09-30	2024-03-31	2023-12-31	2023-09-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2014-06-30	2013-03-31	2012-12-31	2012-09-30	2012-03-31	2011-12-31	2011-09-30	2011-06-30	2011-03-31	2010-12-31	2010-09-30	2010-06-30	2009-06-30	2009-03-31

cash flows from operating activities:
net earnings	1,249,500,000	963,200,000	956,300,000	1,184,900,000	878,400,000	859,400,000	1,043,100,000	813,200,000	779,000,000	625,500,000	928,500,000	694,400,000	700,500,000	538,200,000	810,700,000	647,500,000	602,100,000		337,100,000	482,700,000	390,800,000	305,300,000	452,400,000	375,000,000	302,700,000	241,800,000	423,800,000	310,100,000	278,500,000	207,900,000	352,600,000	402,700,000
adjustments to reconcile net earnings to cash flows from operating activities:
depreciation and amortization	147,000,000	151,100,000	138,600,000	144,600,000	140,100,000	141,500,000	137,000,000	136,800,000	135,100,000	130,500,000	129,000,000	126,500,000	129,100,000	126,000,000	126,900,000	126,700,000	131,100,000		99,500,000	81,100,000	77,300,000	78,300,000	81,100,000	79,200,000	79,700,000	79,000,000	81,000,000	82,700,000	75,500,000	76,400,000	79,300,000	77,600,000
amortization of deferred contract costs	286,100,000	284,500,000	281,400,000	268,300,000	264,400,000	262,300,000	249,500,000	245,100,000	243,500,000	240,900,000	239,400,000	237,600,000	237,300,000	234,800,000	235,600,000	232,600,000	232,300,000
deferred income taxes	-15,300,000	-10,200,000	42,700,000	-26,900,000	-4,300,000	26,800,000	-27,500,000	-10,600,000	20,500,000	34,500,000	-44,300,000	20,800,000	25,600,000	-212,800,000	-39,600,000	-22,200,000	23,500,000		-53,700,000	800,000	-4,500,000	7,100,000	700,000	-2,500,000	9,700,000	55,800,000	34,600,000	9,600,000	7,600,000	45,300,000	-18,800,000	23,300,000
stock-based compensation expense	62,800,000	79,100,000	60,600,000	56,300,000	73,600,000	58,800,000	67,600,000	58,400,000	50,600,000	55,500,000	48,300,000	55,600,000	42,300,000	48,900,000	45,500,000	47,100,000	33,800,000		74,100,000	22,400,000	24,300,000	17,600,000	20,400,000	27,100,000	18,600,000	17,800,000	21,800,000	22,800,000	13,900,000	12,600,000	10,500,000	22,900,000
bad debt expense	17,100,000	11,900,000	11,200,000
net pension income	-5,000,000	-4,900,000	-4,900,000	-5,800,000	-5,800,000	-5,800,000	-10,700,000	-10,700,000	-9,300,000		-15,800,000	-15,800,000	-15,800,000		-13,900,000	-10,900,000	-11,100,000
net accretion of discounts and amortization of premiums on available-for-sale securities	-18,300,000	-16,000,000	-15,500,000	-11,800,000	-11,900,000	-5,500,000
other	6,100,000	3,800,000	900,000	-22,300,000	14,200,000	2,700,000	17,800,000	20,200,000	10,600,000	37,300,000	-11,400,000	3,600,000	3,200,000	17,000,000	15,800,000	-3,700,000	6,100,000		-42,800,000	7,500,000	4,000,000	9,700,000	16,800,000	-3,100,000	4,300,000	2,600,000	-1,100,000	20,800,000	12,800,000	-800,000	39,400,000	900,000
changes in operating assets and liabilities:
increase in accounts receivable	-44,000,000									47,100,000	-507,600,000	25,800,000	-51,800,000	25,400,000	-278,700,000	-7,800,000	-78,700,000		140,200,000											-17,200,000	-3,600,000	67,700,000
increase in deferred contract costs	-325,500,000	-295,500,000	-269,800,000	-327,900,000	-276,100,000	-261,900,000
increase in other assets	116,100,000	-53,900,000	-217,100,000	87,900,000	-8,700,000	-304,900,000	-197,800,000	-283,900,000	-504,000,000	-321,500,000	-268,300,000	-174,400,000	-494,200,000	-235,400,000	-150,700,000	-188,500,000	-454,800,000		60,500,000	14,500,000	2,300,000	-330,500,000	-15,900,000	-5,400,000	-117,700,000				-106,300,000			-2,100,000
increase/(decrease) in accounts payable	-40,400,000	34,400,000	48,000,000											27,100,000			5,700,000
increase/(decrease) in accrued expenses and other liabilities														73,800,000									100,900,000
net cash flows from operating activities	1,525,800,000	1,150,300,000	824,400,000	1,498,100,000	1,032,400,000	326,500,000	1,404,100,000	899,700,000	718,100,000	912,900,000	971,000,000	1,093,700,000	121,900,000	652,800,000	1,252,200,000	706,400,000	481,900,000		819,700,000	618,300,000			663,200,000	431,600,000	316,300,000	485,500,000	573,000,000	425,000,000	222,300,000	395,500,000	427,500,000	453,500,000
cash flows from investing activities:
purchases of corporate and client funds marketable securities	-1,665,700,000	-1,219,000,000	-2,771,700,000	-3,060,200,000	-595,300,000	-710,200,000	-1,764,000,000	-642,600,000	-3,064,500,000	-1,789,200,000	-3,720,700,000	-2,810,700,000	-2,412,600,000	-2,118,000,000	-3,593,500,000	-2,742,000,000	-812,800,000		422,700,000	-1,677,200,000	-1,394,900,000	-765,500,000	-1,417,100,000	-1,138,000,000	-1,095,100,000	-1,149,600,000	-1,053,600,000	-1,482,400,000	-1,085,300,000	-1,161,400,000	-480,500,000	-520,400,000
proceeds from the sales and maturities of corporate and client funds marketable securities	1,258,800,000	1,257,300,000	1,266,800,000	2,121,400,000	871,200,000	632,000,000	1,355,800,000	907,000,000	1,618,600,000	882,800,000	1,370,000,000	717,800,000	1,279,100,000	1,078,800,000	2,327,100,000	1,635,800,000	1,196,700,000		-802,000,000	1,024,300,000	1,234,700,000	602,500,000	852,100,000			989,200,000	756,500,000	732,500,000	826,900,000	814,000,000	1,068,700,000	755,300,000
capital expenditures	-36,400,000	-39,400,000	-58,800,000	-59,600,000	-54,800,000	-39,300,000	-50,300,000	-49,700,000	-45,400,000	-47,600,000	-51,000,000	-39,900,000	-35,900,000	-33,300,000	-64,300,000	-37,500,000	-43,500,000		-94,300,000	-47,000,000	-44,800,000	-30,500,000	-37,800,000	-33,200,000	-33,400,000	-59,800,000	-41,400,000	-42,100,000	-38,600,000	-26,400,000	-45,500,000	-28,800,000
free cash flows	1,489,400,000	1,110,900,000	765,600,000	1,438,500,000	977,600,000	287,200,000	1,353,800,000	850,000,000	672,700,000	865,300,000	920,000,000	1,053,800,000	86,000,000	619,500,000	1,187,900,000	668,900,000	438,400,000		725,400,000	571,300,000			625,400,000	398,400,000	282,900,000	425,700,000	531,600,000	382,900,000	183,700,000	369,100,000	382,000,000	424,700,000
additions to intangibles	-101,100,000	-94,800,000	-80,900,000	-97,500,000	-78,700,000	-87,000,000	-106,900,000	-92,100,000	-86,300,000	-96,700,000	-101,600,000	-87,500,000	-93,200,000	-87,100,000	-92,100,000	-71,700,000	-76,400,000		-69,700,000	-22,400,000	-25,500,000	-33,500,000	-31,100,000	-27,400,000	-24,000,000	-36,900,000	-23,100,000	-16,400,000	-19,400,000	-36,300,000	-32,200,000	-27,900,000
acquisitions of businesses, net of cash acquired	-4,500,000			0	0	-33,600,000	-18,000,000			0	0								-10,400,000	-14,600,000	0	-700,000	-23,500,000	-174,400,000	-1,900,000	-1,300,000	-185,900,000	-113,500,000	-475,300,000	-1,100,000	-40,600,000	-19,200,000
proceeds from sale of property, plant, and equipment and other assets	0	0	3,300,000	1,900,000	4,400,000	22,000,000					8,000,000	0	26,200,000		6,000,000	1,600,000	200,000
net cash flows used in investing activities	-555,900,000	-1,257,900,000	-1,644,400,000	-1,094,000,000	138,300,000	-216,100,000	-583,400,000	108,200,000	-1,577,600,000		-2,495,300,000															7,294,200,000	-8,496,700,000					4,077,800,000
cash flows from financing activities:
net increase in client funds obligations	-8,456,000,000										13,612,900,000	-684,800,000	12,100,600,000		4,963,500,000										-5,936,900,000	-7,392,700,000	8,239,500,000	1,805,000,000	3,639,100,000	-7,779,300,000	-5,127,700,000	-4,146,600,000
net cash (distributed)/received from the internal revenue service
payments of debt	-300,000	-300,000	-300,000	-200,000	-300,000	-200,000	-200,000	-300,000	-200,000	-200,000	-200,000	-300,000	-200,000	-200,000	-500,000	-500,000	-1,000,600,000		13,700,000	-8,300,000	-500,000	-8,200,000	-500,000	-500,000	-500,000	-400,000	-600,000	-400,000	-4,300,000	-1,600,000	-400,000	-8,100,000
proceeds from the issuance of debt	0	0	988,900,000											990,400,000	0	0	991,100,000
settlement of cash flow hedges	0	0	-12,500,000											-1,000,000	0	0	-43,600,000
repurchases of common stock	-311,600,000	-272,300,000	-372,600,000	-291,500,000	-254,700,000	-250,000,000	-264,000,000	-220,200,000	-333,300,000	-487,500,000	-491,400,000	-462,500,000	-528,000,000	-469,800,000	-427,400,000	-261,500,000	-213,600,000		-265,300,000	-95,100,000	-112,400,000	-194,500,000	-102,000,000	-48,700,000	-249,200,000	-558,000,000	-72,700,000	-52,300,000	-49,800,000	-487,200,000	0	-129,200,000
net proceeds from stock purchase plan and stock-based compensation plans	60,100,000	26,600,000	12,000,000	42,100,000	19,100,000	-36,600,000	47,900,000	23,800,000	1,000,000	23,000,000	23,100,000	67,100,000	-16,700,000	30,600,000	34,400,000	47,000,000	-7,900,000
dividends paid	-628,000,000	-572,500,000	-572,600,000	-575,900,000	-516,300,000	-515,800,000	-520,600,000	-432,600,000	-432,900,000	-434,300,000	-437,700,000	-393,800,000	-393,200,000	-396,000,000	-397,800,000	-390,700,000	-391,000,000		-288,400,000	-210,400,000	-192,200,000	-192,100,000	-192,500,000	-176,200,000	-177,700,000	-179,200,000	-177,600,000	-167,600,000	-168,000,000	-175,300,000	-165,500,000	-166,700,000
net proceeds related to reverse repurchase agreements	-1,500,000	-641,800,000	297,100,000			273,800,000			54,800,000
net cash flows (used in)/provided by financing activities							3,938,100,000	6,678,300,000	-16,302,600,000
effect of exchange rate changes on cash, cash equivalents, restricted cash, and restricted cash equivalents	24,000,000	-53,700,000	17,000,000	-26,300,000	26,900,000	-16,300,000	-700,000	20,300,000	-44,900,000	-84,500,000	6,700,000	300,000	-21,200,000	3,400,000	-14,300,000	46,800,000	37,900,000	6,900,000
net change in cash, cash equivalents, restricted cash, and restricted cash equivalents	-8,405,000,000	13,812,700,000	-7,294,500,000	6,245,500,000	6,917,400,000	-1,809,600,000	4,758,100,000	7,706,500,000	-17,207,000,000	-8,947,600,000	11,196,400,000	-2,658,100,000	10,049,100,000	-6,978,600,000	3,993,300,000	5,766,800,000	3,308,100,000	-1,465,400,000
cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of period	0	0	10,086,000,000	0	0	8,771,500,000	0	0	22,783,000,000		0	0	13,143,200,000		0	0	7,053,600,000
cash, cash equivalents, restricted cash, and restricted cash equivalents, end of period	-8,405,000,000	13,812,700,000	2,791,500,000	6,245,500,000	6,917,400,000	6,961,900,000	4,758,100,000	7,706,500,000	5,576,000,000		11,196,400,000	-2,658,100,000	23,192,300,000		3,993,300,000	5,766,800,000	10,361,700,000
reconciliation of cash, cash equivalents, restricted cash, and restricted cash equivalents to the consolidated balance sheets
cash and cash equivalents	464,200,000	111,500,000	2,104,900,000	1,650,400,000	199,900,000	1,441,400,000	483,400,000	137,300,000	1,207,700,000	-197,900,000	-110,800,000	142,900,000	1,602,100,000	683,700,000	289,300,000	-10,900,000	1,613,100,000
restricted cash and restricted cash equivalents included in funds held for clients	-8,869,200,000	13,701,200,000	686,600,000	4,595,100,000	6,717,500,000	5,520,500,000	4,274,700,000	7,569,200,000	4,368,300,000	-8,749,700,000	11,307,200,000	-2,801,000,000	21,590,200,000	-7,662,300,000	3,704,000,000	5,777,700,000	8,748,600,000
total cash, cash equivalents, restricted cash, and restricted cash equivalents	-8,405,000,000	13,812,700,000	2,791,500,000	6,245,500,000	6,917,400,000	6,961,900,000	4,758,100,000	7,706,500,000	5,576,000,000	-8,947,600,000	11,196,400,000	-2,658,100,000	23,192,300,000	-6,978,600,000	3,993,300,000	5,766,800,000	10,361,700,000
supplemental disclosures of cash flow information:
cash paid for interest	90,400,000	108,800,000	140,700,000	68,100,000	95,800,000	97,000,000	44,000,000	47,800,000	56,700,000	17,700,000	24,000,000	9,200,000	23,900,000	800,000	24,200,000	800,000	27,300,000
cash paid for income taxes, net of income tax refunds	253,400,000	518,800,000	64,700,000	215,700,000	502,500,000	87,900,000	241,700,000	479,600,000	57,500,000	268,900,000	222,200,000	310,700,000	55,000,000	403,600,000	207,400,000	317,300,000	45,400,000
decrease in accrued expenses and other liabilities		212,900,000	-323,400,000		231,500,000	-308,600,000		116,000,000	-194,700,000			50,500,000	-413,800,000			-135,800,000	-23,100,000					-73,000,000			-78,800,000		134,300,000	-92,300,000	-68,600,000
net cash distributed from the internal revenue service		-151,200,000	-336,400,000
net cash flows from financing activities											12,714,000,000	-1,520,100,000	11,184,800,000							6,426,700,000			6,243,500,000	3,975,600,000	-6,315,400,000	-7,996,600,000	8,205,500,000	1,691,500,000	3,438,800,000		-4,554,500,000	-4,474,600,000
(increase)/decrease in accounts receivable			115,400,000			-107,900,000															-137,300,000	-73,400,000
net decrease in client funds obligations			-10,870,500,000			-1,374,900,000																-1,220,400,000
net proceeds of commercial paper borrowings			4,375,400,000
net cash flows used in financing activities			-6,491,500,000			-1,903,700,000																-1,093,300,000
decrease in accounts payable				9,900,000	11,400,000	-30,400,000	-11,100,000	10,200,000	-30,700,000											12,400,000	2,300,000	-31,400,000	2,400,000	10,300,000	-26,500,000		15,900,000	-22,100,000	-36,600,000			-5,800,000
net increase/(decrease) in client funds obligations				5,577,700,000													3,203,300,000
net cash received from the internal revenue service
net payments related to reverse repurchase agreements				-16,500,000			-9,500,000				0				0
net cash flows provided by/(used in) financing activities				5,867,700,000										-6,486,200,000			2,524,100,000
net amortization of premiums and accretion of discounts on available-for-sale securities							1,900,000	7,600,000	16,000,000	24,900,000	27,600,000	25,800,000	22,700,000	20,800,000	20,000,000	16,300,000	12,400,000		36,600,000	19,900,000	19,200,000	18,700,000	15,900,000			12,800,000	13,700,000	14,100,000	13,000,000	13,700,000	14,800,000	14,600,000
decrease/(increase) in accounts receivable									201,500,000
(decrease)/increase in accrued expenses and other liabilities
net (decrease)/increase in client funds obligations							4,684,500,000	7,495,200,000	-15,592,000,000
net pension (income)/expense
(decrease)/increase in accounts payable										24,900,000	-21,400,000	42,000,000	-61,900,000
proceeds from the sale of property, plant, and equipment and other assets																			-9,600,000	0
net cash flows (used in)/provided by investing activities													-1,236,400,000	-1,148,600,000
net increase /(decrease) in client funds obligations
net proceeds/(payments) related to reverse repurchase agreements													22,300,000
cash, cash equivalents, restricted cash, and restricted cash equivalents, beginning of year
cash, cash equivalents, restricted cash, and restricted cash equivalents, end of year
increase in accrued expenses and other liabilities																			114,300,000	105,600,000										110,300,000	-31,900,000	-163,200,000
impairment of assets														12,300,000	2,600,000	2,200,000	2,800,000
gain on sale of assets													-1,300,000	-6,400,000	-1,600,000	-1,600,000	-200,000						0
increase in accounts payable
net cash flows from investing activities																	264,200,000				-2,859,700,000	715,900,000		-4,314,000,000	5,882,100,000				-4,155,700,000
net (payments)/proceeds related to reverse repurchase agreements																	-13,600,000
cash provided by:
operating activities
investing activities
financing activities
net pension expense																			-3,000,000	10,900,000	10,900,000	10,900,000	9,200,000	9,100,000	9,200,000	10,400,000	10,100,000	10,100,000	10,100,000	8,700,000	8,700,000	8,300,000
impairment of intangible assets
changes in operating assets and liabilities, net of effects from acquisitions:
(decrease) / increase in accounts payable
(decrease) / increase in accrued expenses and other liabilities
net cash flows from / (used in) investing activities
net payments of reverse repurchase agreements
net cash flows (used in) / provided by financing activities
gain on sale of divested businesses, net of tax
changes in operating assets and liabilities, net of effects from acquisitions and divestitures of businesses:
proceeds from the sale of divested businesses
net proceeds from reverse repurchase agreements																					-428,200,000	441,700,000
decrease/(increase) in other assets
proceeds from debt issuance
gain on sale of building																														3,800,000
proceeds from the sale of notes receivable
operating activities of discontinued operations																			-1,200,000	0	1,300,000	100,000								0
net decrease/(increase) in restricted cash and cash equivalents held to satisfy client funds obligations
dividend received from cdk global, inc.
cash retained by cdk global, inc.
investing activities of discontinued operations																			100,000	0										0
net cash flows provided by/(used in) investing activities
proceeds from stock purchase plan and exercises of stock options																			29,800,000	59,800,000	49,300,000	80,200,000	72,100,000	69,300,000	48,900,000	132,700,000	216,900,000	106,800,000	21,800,000	39,800,000	7,600,000	-24,000,000
net repayments from issuance of commercial paper
financing activities of discontinued operations
effect of exchange rate changes on cash and cash equivalents																			4,400,000	-12,600,000	4,400,000	11,800,000	10,000,000	-10,800,000	-23,500,000	5,400,000	13,400,000	-5,100,000	28,000,000	-15,600,000	35,400,000	1,800,000
net change in cash and cash equivalents																			184,900,000	256,800,000	273,500,000	-430,700,000	333,800,000	82,400,000	-140,500,000	-211,500,000	295,200,000	129,000,000	-466,600,000	-321,700,000	901,900,000	58,500,000
cash and cash equivalents, beginning of period																							0	0	1,389,400,000		0	0	1,643,300,000
cash and cash equivalents, end of period																							333,800,000	82,400,000	1,248,900,000		295,200,000	129,000,000	1,176,700,000
excess tax benefit related to exercise of stock options and restricted stock
net realized loss / (gain) from the sales of marketable securities
net (increase) / decrease in restricted cash and cash equivalents held to satisfy client funds obligations
net cash flows (used in) / provided by investing activities
net increase / (decrease) in client funds obligations
net repayments from reverse repurchase agreements
net (repayments) / proceeds from issuance of commercial paper
net cash flows from / (used in) financing activities
less cash and cash equivalents of discontinued operations, end of period
cash and cash equivalents of continuing operations, end of period																			335,900,000	256,800,000	273,500,000	1,117,400,000
net realized gain from the sales of marketable securities																			3,300,000	-6,000,000	-9,300,000	-4,500,000	-3,600,000	-8,200,000	-4,000,000				-11,800,000		-2,500,000	6,600,000
goodwill impairment
gains on sales of buildings																				0							0	0	-1,800,000
gain on sale of discontinued businesses, net of tax																			26,200,000	0											-5,400,000	0
increase / (decrease) in accounts payable
proceeds from the sale of businesses included in discontinued operations																			-137,000,000	0										0
net (repayments of) / proceeds from reverse repurchase agreements
net (repayments of) / proceeds from issuance of commercial paper
impairment losses on available-for-sale securities																							0							9,100,000
impairment losses on assets held for sale																										3,100,000	0	0	8,600,000
changes in operating assets and liabilities, net of effects from acquisitions
and divestitures of businesses:
net decrease / (increase) in restricted cash and cash equivalents held to satisfy client funds obligations
net (decrease) / increase in client funds obligations
net proceeds from issuance of commercial paper
cash and cash equivalents of continuing operations, beginning of period																			151,000,000	0	0	1,548,100,000										0
adjustments to reconcile net earnings to cash flows from operating activities
changes in operating assets and liabilities, net of effects from acquisitions and divestiture of business:
net increase in restricted cash and cash equivalents held to satisfy client funds obligations																											-7,947,700,000	-1,064,100,000	-3,380,400,000
adjustments to reconcile net earnings to cash flows provided by
operating activities:
net (increase)/decrease in restricted cash and cash equivalents held to satisfy client funds obligations
net cash flows (used in)/provided by operating activities																						-65,100,000
net decrease in restricted cash and cash equivalents held to satisfy client funds obligations																						943,600,000
proceeds from the sale of property, plant and equipment and other assets																							0
decrease in accounts receivable																								-103,900,000	106,300,000				27,400,000
net amortization of premiums and accretion of discounts
on available-for-sale securities																									12,800,000
changes in operating assets and liabilities, net of effects
from acquisitions and divestitures of businesses:
proceeds from the sales and maturities of corporate
and client funds marketable securities																									844,300,000
net decrease (increase) in restricted cash and cash equivalents
held to satisfy client fund obligations																									6,192,200,000
proceeds from the sale of property, plant and equipment																										0	0	100,000	13,000,000	0	5,800,000	0
cash flows from operating activities
excess tax benefit related to exercises of stock options
net realized (gain) income from the sales of marketable securities
gain on sales of buildings
(increase) in accounts receivable
cash flows from investing activities
net increase in restricted cash and cash equivalents and other restricted assets held to satisfy client funds obligations																															4,515,000,000	3,915,900,000
reclassification from cash and cash equivalents to short-term marketable securities																															0	0
cash flows from financing activities
proceeds from issuance of debt																															0	0
net purchases of reverse repurchase agreements																																0
net (repayment) proceeds of commercial paper borrowing
cash and cash equivalents of continuing operations, beginning of year
cash and cash equivalents of discontinued operations, beginning of year
cash and cash equivalents, end of year
less cash and cash equivalents of discontinued operations, end of year
cash and cash equivalents of continuing operations, end of year
net realized (gain)/income from the sales of marketable securities																											-4,300,000
(increase)/decrease in other assets																											-12,500,000
net repayment of commercial paper
changes in operating assets and liabilities, net of effects from acquistions and divestitures of businesses:
decrease (increase) in other assets																														-125,100,000
net (purchases of) proceeds from reverse repurchase agreements
net cash flows from (used in) financing activities
net realized income from the sales of marketable securities
(gain) loss on sale of discontinued businesses, net of tax
net increase in restricted cash and cash equivalents and other restricted assets
held to satisfy client funds obligations
net repayment of commercial paper borrowing
cash and cash equivalents of discontinued operations, beginning of period
gain on sale of cost-based investment
(increase) in other assets
proceeds from the sale of cost-based investment
dividend received from broadridge financial solutions, inc., net of 29.9 million in cash retained by broadridge financial solutions, inc.
proceeds from the sale of businesses included in discontinued operations, net of cash divested
gain on sale of assets held for sale																																0
impairment of assets of discontinued operations businesses
decrease (increase) in accounts receivable
net decrease (increase) in restricted cash and cash equivalents and other restricted assets held to satisfy client funds obligations
see notes to consolidated financial statements.

We provide you with 20 years of cash flow statements for ADP LLC stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of ADP LLC stock. Explore the full financial landscape of ADP LLC stock with our expertly curated income statements.

The information provided in this report about ADP LLC stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.